CAPR

Capricor Therapeutics, Inc. Common Stock

$2.48 +$0.10 +4.03%



Shares Bought2
Shares Sold2
Total4
Shares Owned0
Last Price$2.48
Total Return-$0.41
Range Today$2.27 - $2.59
52 Week Range$0.63 - $4.25
Open$2.36
Market Cap$53.78M
Volume/Average469.92K/834.00K
P/E Ratio-
Dividend/Yield-




Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
10-03-17 16:51 10-04-17 17:36 $3.12 $3.31 +$0.19 +6.09% genovahero
10-02-17 15:36 10-04-17 15:45 $3.85 $3.25 -$0.60 -15.58% funkmasterflexion genovahero